Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Express Scripts Holding Co.

Latest From Express Scripts Holding Co.

Biogen Ventures Into Value-Based Contracts In Multiple Sclerosis

Four contracts test approaches tying reimbursement to relapse rates and discontinuation of treatment. Payers involved include Harvard Pilgrim and Intermountain's SelectHealth.

Reimbursement Pricing Strategies

Large Employers Exploring Value-Based Contracting For Specialty Drugs

National Business Group on Health annual survey of employer-sponsored insurance finds continued concerns with specialty drug costs, growing interest in using accountable care organizations to control costs.

Private Payers Reimbursement

CVS 2018 Formulary: Outcomes-Based Contracts In Oncology, Obesity, COPD

And for diabetes, Jardiance is out and Invokana is in; CVS formulary update includes far fewer exclusions than previous years and reinstates coverage for several drugs, signaling more muted approach to management.

Pricing Strategies Pharmacy Benefit Management

Exclusive Remicade Contracts Are Slowing Biosimilar Uptake

Exclusive contracts for J&J's Remicade have posed challenges for Pfizer's Inflectra in the commercial insurance market, the biosimilar's maker said during its second quarter earnings call.

Biosimilars Reimbursement
See All

Company Information